Abstract
Seven non-diabetic patients with chronic pancreatitis were shown to have a diminished acute insulin secretory response after intensive beta cell and intravenous tolbutamide stimulation. In an attempt to unmask their ‘latent’ diabetic state, triamcinolone-augmented glucose tolerance tests were performed some days after documenting normal standard 50 g oral glucose tolerance tests. A matched group of non-diabetic controls was similarly investigated. Although the steroid-augmented glucose tolerance tests showed marked impairment in the patients, becoming frankly diabetic in three cases, the normal control subjects reacted in a similar though less striking fashion. There was no significant difference between the mean glucose values in the two groups. The ability of patients with chronic pancreatitis to maintain normal glucose tolerance in the face of diminished insulin output is commented on. We conclude that, as an ancillary investigation for diagnosing chronic pancreatitis, the triamcinolone glucose tolerance test is unreliable.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson M. F., Davison S. H., Dick A. P., Hales C. N., Owens J. Plasma insulin in pancreatic disease. Gut. 1970 Jun;11(6):524–531. doi: 10.1136/gut.11.6.524. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berger S., Downey J. L., Traisman H. S., Metz R. Mechanism of the cortisone-modified glucose tolerance test. N Engl J Med. 1966 Jun 30;274(26):1460–1464. doi: 10.1056/NEJM196606302742602. [DOI] [PubMed] [Google Scholar]
- Deckert T., Kolendorf K., Persson I., Worning H. Insulin secretion after tolbutamide and after secretin in patients with pancreatic diseases. Acta Med Scand. 1972 Nov;192(5):465–470. doi: 10.1111/j.0954-6820.1972.tb04847.x. [DOI] [PubMed] [Google Scholar]
- HALES C. N., RANDLE P. J. Immunoassay of insulin with insulin-antibody precipitate. Biochem J. 1963 Jul;88:137–146. doi: 10.1042/bj0880137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jackson W. P., Campbell G. D., Marine N., Major V., Seedat Y. K. Triamcinolone-augmented glucose tolerance in offspring of diabetic couples. Metabolism. 1972 Sep;21(9):807–814. doi: 10.1016/0026-0495(72)90003-0. [DOI] [PubMed] [Google Scholar]
- Joffe B. I., Bank S., Jackson W. P., Keller P., O'Reilly I. G., Vinik A. I. Insulin reserve in patients with chronic pancreatitis. Lancet. 1968 Oct 26;2(7574):890–892. doi: 10.1016/s0140-6736(68)91055-6. [DOI] [PubMed] [Google Scholar]
- Joffe B. I., Bank S., Marks I. N. Hypoglycaemia in pancreatitis. Lancet. 1968 Nov 9;2(7576):1038–1038. doi: 10.1016/s0140-6736(68)91333-0. [DOI] [PubMed] [Google Scholar]
- Levine R. Mechanisms of insulin secretion. N Engl J Med. 1970 Sep 3;283(10):522–526. doi: 10.1056/NEJM197009032831009. [DOI] [PubMed] [Google Scholar]
- NAVARRETE V. N., TORRES I. H. A TRIAMCINOLONE-GLUCOSE TOLERANCE TEST IN THE EARLY DIAGNOSIS OF DIABETES. Diabetes. 1965 Aug;14:481–488. doi: 10.2337/diab.14.8.481. [DOI] [PubMed] [Google Scholar]
- Persson I., Gyntelberg F., Heding L. G., Boss-Nielsen J. Pancreatic-glucagon-like immunoreactivity after intravenous insulin in normals and chronic-pancreatitis patients. Acta Endocrinol (Copenh) 1971 Jun;67(2):401–404. doi: 10.1530/acta.0.0670401. [DOI] [PubMed] [Google Scholar]
- Porte D., Jr, Bagdade J. D. Human insulin secretion: as integrated approach. Annu Rev Med. 1970;21:219–240. doi: 10.1146/annurev.me.21.020170.001251. [DOI] [PubMed] [Google Scholar]
- Ryan W. G., Nibbe A. F., Schwartz T. B. Beta-cytotrophic effects of glucose, glucagon, and tolbutamide in man. Lancet. 1967 Jun 10;1(7502):1255–1256. doi: 10.1016/s0140-6736(67)92717-1. [DOI] [PubMed] [Google Scholar]
- Vinik A. I., Joffe B. I., Joubert S. M., Jackson W. P. Growth hormone response to insulin-induced hypoglycemia in diabetes secondary to chronic calcific pancreatitis. J Clin Endocrinol Metab. 1970 Jul;31(1):86–88. doi: 10.1210/jcem-31-1-86. [DOI] [PubMed] [Google Scholar]